Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19
NCT04653727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1287
Last updated 2022-09-29
Summary
The outbreak of the novel coronavirus SARS-CoV-2 caused a health emergency of international proportions when it was declared by the World Health Organization (WHO) in January 2020. Since then, the virus has spread internationally and the WHO has classified the outbreak as a pandemic. In the context of the increasing reporting of this pandemic and the increasing governmental measures to limit or slow down the spread of SARS-CoV-2 by all means, there is so far little scientific evidence for the effects of a healthy lifestyle on the disease. The aim of this study is to compare the potential of different, possibly protective lifestyles using the example of the COVID-19 pandemic. We will conduct an online survey with 3.000 participants using mobile website technology.
Conditions
- Covid19
- Influenza A
- Respiratory Disease
Interventions
- OTHER
-
Cross-sectional survey
No intervention.
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-06
- Primary Completion
- 2021-03-05
- Completion
- 2021-03-05
Countries
- Germany
Study Locations
More Related Trials
-
Integrative Therapy of Chronic Diseases
NCT04927403 ·Status: UNKNOWN
-
Effect of Traditional Chinese Medicine of Severe COVID-19
NCT06714032 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT05672498 ·Status: UNKNOWN ·Phase: NA
-
Traditional Chinese Medicine for Severe COVID-19
NCT04323332 ·Status: UNKNOWN ·Phase: PHASE3
-
Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak
NCT04345549 ·Status: COMPLETED ·Phase: NA
-
Elderberry for Immune Support
NCT05435144 ·Status: UNKNOWN ·Phase: NA
-
Moxibustion Plus Cupping in Convalescent Patients With COVID-19
NCT04374084 ·Status: UNKNOWN ·Phase: NA
-
Ayurveda for Flu Like Illness During Covid-19 Outbreak
NCT04351542 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus
NCT04323345 ·Status: UNKNOWN ·Phase: PHASE3
-
Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents
NCT04668222 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Ayurveda as Prophylaxis for Suspected COVID-19 Patients
NCT04395976 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
NCT04844710 ·Status: COMPLETED ·Phase: NA
-
Acupuncture and Chinese Herbal Medicine for Long COVID
NCT07285707 ·Status: RECRUITING ·Phase: NA
-
Acceptance of Complementary Medicine in Germany
NCT05530720 ·Status: COMPLETED
-
Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Completely Masked Trial
NCT01414335 ·Status: COMPLETED ·Phase: NA
-
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
NCT04790240 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cupping Therapy on Immune System in Post Covid -19
NCT05901337 ·Status: COMPLETED ·Phase: NA
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia
NCT03185923 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China
NCT07196917 ·Status: NOT_YET_RECRUITING
-
Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection
NCT01008020 ·Status: COMPLETED ·Phase: NA
-
Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia
NCT05692258 ·Status: UNKNOWN ·Phase: NA
-
Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870 ·Status: NOT_YET_RECRUITING
-
TCM Differentiation and Treatment Protocol of COVID-19
NCT04306497 ·Status: COMPLETED
-
Sauna Detoxification Study: Pilot Feasibility
NCT01576822 ·Status: COMPLETED ·Phase: PHASE1
-
A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection
NCT02539277 ·Status: UNKNOWN ·Phase: PHASE4